HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?

被引：33
|
作者：
Furukawa, Hiroshi [1 ]
Oka, Shomi
Shimada, Kota [2 ,3 ]
Tsuchiya, Naoyuki [4 ]
Tohma, Shigeto
机构：
[1] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan
[2] Sagamihara Hosp, Natl Hosp Org, Dept Rheumatol, Sagamihara, Kanagawa 2520392, Japan
[3] Tokyo Metropolitan Tama Med Ctr, Fuchu, Tokyo, Japan
[4] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷 / 01期
关键词：
STEVENS-JOHNSON-SYNDROME; HLA-B; ASSOCIATION; ABACAVIR; ALLELE;
D O I：
10.1136/annrheumdis-2012-201944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：153 / 155
页数：3
相关论文
共 50 条
  • [41] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Vanesa Bejarano, Marisel
    Natalia Tamborenea, Maria
    Goni, Mario
    Saldarriaga, Lina
    Pisoni, Cecilia
    Garcia Salinas, Rodrigo
    Salcedo, Mariana
    Helling, Claudia
    Salas, Adrian
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 12 - 13
  • [42] Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung Disease
    Otsuji, Naotatsu
    Sugiyama, Kumiya
    Owada, Takayoshi
    Arifuku, Hajime
    Koyama, Kenya
    Hirata, Hirokuni
    Fukushima, Yasutsugu
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2024, 16 : 127 - 135
  • [43] INTERSTITIAL LUNG DISEASE IMPROVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND TOFACITINIB
    Madariaga Charaja, Hugo Javier
    Elena Luza, Maria
    Ponce de Leon, Dario
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S48 - S48
  • [44] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Bejarano, Marisel
    Natalia Tamborenea, Maria
    Alberto Goni, Mario
    Saldarriaga, Lina
    Pisoni, Cecilia
    Garcia Salinas, Rodrigo
    Salcedo, Mariana
    Helling, Claudia
    Salas, Adrian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1672 - 1672
  • [45] Rituximab improves interstitial lung disease in rheumatoid arthritis patients
    Barbero, Ma Asuncion Nieto
    Font, Cristina Vadillo
    Alcala, Mariara Calderon
    Urgelles, Judit Font
    Bobillo, Juan Rigual
    Nunez, Dalifer Freites
    Alcazar, Lydia Abasolo
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [46] RISK FACTORS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kur-Zalewska, J.
    Tlustochowicz, M.
    Tlustochowicz, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 173 - 173
  • [47] Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis
    Dam Kim
    Soo-Kyung Cho
    Chan-Bum Choi
    Jung-Yoon Choe
    Won Tae Chung
    Seung-Jae Hong
    Jae-Bum Jun
    Young Ok Jung
    Tae-Hwan Kim
    Tae-Jong Kim
    Hye-Soon Lee
    Joo-Hyun Lee
    Jisoo Lee
    Shin-Seok Lee
    Dae-Hyun Yoo
    Bo Young Yoon
    Jin Woo Song
    Sang-Cheol Bae
    Yoon-Kyoung Sung
    Rheumatology International, 2017, 37 : 1735 - 1745
  • [48] Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
    Matteson, Eric L.
    Bendstrup, Elisabeth
    Strek, Mary E.
    Dieude, Philippe
    ACR OPEN RHEUMATOLOGY, 2024, 6 (12) : 836 - 845
  • [49] Incidence and risk factors for methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis.
    Cannon, GW
    Cerveny, KC
    Finck, BK
    Simpson, KM
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S166 - S166
  • [50] Methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis in large clinical trials.
    Cannon, GW
    Finck, BK
    Simspon, KM
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S341 - S341
12345